Related Experiment Videos

Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria

James H Jorgensen¹

¹Department of Pathology, The University of Texas Health Science Center, San Antonio, Texas 78229, USA. jorgensen@uthscsa.edu

Journal of Clinical Microbiology

|February 10, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019

Comparative Genome Analysis of the Daptomycin-Resistant Streptococcus anginosus Strain J4206 Associated with Breakthrough Bacteremia.

Genome biology and evolution·2016

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.

The Lancet. Respiratory medicine·2016

Complete Genome Sequence of Streptococcus anginosus J4211, a Clinical Isolate.

Genome announcements·2015

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

The Lancet. Infectious diseases·2015

Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments.

The Journal of infectious diseases·2014

See all related articles